| mRNA |
Erlotinib |
gCSI |
pan-cancer |
AAC |
0.29 |
5e-06 |
| mRNA |
Erlotinib |
CCLE |
pan-cancer |
AAC |
0.21 |
8e-06 |
| mRNA |
CGP-082996 |
GDSC1000 |
pan-cancer |
AAC |
0.24 |
4e-05 |
| mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.15 |
6e-05 |
| mRNA |
lapatinib |
gCSI |
pan-cancer |
AAC |
0.23 |
0.0001 |
| mRNA |
Erlotinib |
GDSC1000 |
pan-cancer |
AAC |
0.21 |
0.0002 |
| mRNA |
SNX-2112:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.0002 |
| mRNA |
GSK461364 |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.0003 |
| mRNA |
FQI-2 |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.0004 |
| mRNA |
BI-2536 |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.0004 |